June 2019

Proactive Investors Interview with Brent Barnes
||
Brent Barnes updates Proactive Investors on developments to forge ahead with product sales of its unique APAS Independence technology. 
continue reading
Evaluation of APAS® Independence for routine urine culture reading within a private clinical setting
As culture reading can be highly subjective and time-demanding the use of artificial intelligence such as the APAS®…
continue reading
LBT Presentation, FNN Investor Event
||
Our CEO presents on LBT's automated plate reading device for use in laboratories, regulatory clearance in the US and the size of the market opportunity.
continue reading